We are live on ! Find out more
BC

Birchview Capital Portfolio holdings

AUM $176M
1-Year Est. Return 95.04%
This Fund
S&P 500
This Quarter Est. Return
+1.09%
1 Year Est. Return
+95.04%
3 Year Est. Return
+233.14%
5 Year Est. Return
+280.2%
10 Year Est. Return
+1,023.63%
AUM
$101M
AUM Growth
-$14.5M
Cap. Flow
-$1.16M
Cap. Flow %
-1.15%
Top 10 Hldgs %
56.77%
Holding
80
New
12
Increased
15
Reduced
13
Closed
9

Top Buys

Rank Stock Value
1
KLAC icon
KLA
KLAC
+$11.9M
2
OVV icon
Ovintiv
OVV
+$2.03M
3
NVCR icon
NovoCure
NVCR
+$1.22M
4
PRTA icon
Prothena Corp
PRTA
+$886K
5
GPCR icon
Structure Therapeutics
GPCR
+$792K

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$17.8M
2
ACAD icon
Acadia Pharmaceuticals
ACAD
+$1.41M
3
UTHR icon
United Therapeutics
UTHR
+$971K
4
TVTX icon
Travere Therapeutics
TVTX
+$580K
5
MASI
Masimo
MASI
+$479K

Sector Composition

Rank Sector Weight
1 Healthcare 79.06%
2 Technology 14.1%
3 Energy 6.07%
4 Materials 0.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LQDA icon
76
Liquidia Corp
LQDA
$7.67B
– –
-10,013
Closed -$148K
LUNG icon
77
Pulmonx
LUNG
$49.4M
– –
-51,000
Closed -$343K
SWTX
78
DELISTED
SpringWorks Therapeutics
SWTX
– –
-8,280
Closed -$365K
TECL icon
79
Direxion Daily Technology Bull 3x ETF
TECL
$5.14B
– –
-20,000
Closed -$144K
TSVT
80
DELISTED
2seventy bio
TSVT
– –
-15,500
Closed -$76.6K
1 2 3
4

Similar funds

RWA
Resolute Wealth Advisor Findlay, Ohio $176M AUM
BAM
Boyar Asset Management New York $176M AUM 20.04% 1-Year Est. Return
TIM
Tevis Investment Management Plano, Texas $176M AUM 18.14% 1-Year Est. Return
LWM
Lifetime Wealth Management Rockwall, Texas $176M AUM
PFA
Providence Financial Advisors Overland Park, Kansas $175M AUM
DAM
Draper Asset Management Smithtown, New York $176M AUM 37.45% 1-Year Est. Return
AF
Align Financial Hermantown, Minnesota $176M AUM
OA
Oceanside Advisors Mount Pleasant, South Carolina $175M AUM 17.96% 1-Year Est. Return

Birchview Capital's Q2 2025 Portfolio in Review

As of Q2 2025, Birchview Capital held 80 positions worth $101M, down 13% from $115M the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Birchview Capital's Q2 2025 filing shows 12 new, 15 increased, 13 reduced and 9 closed positions. Its largest new stake was KLA: 158,480 shares worth $14.2M. The largest sale was Bristol-Myers Squibb, an estimated $17.8M.

By sector, the portfolio is most concentrated in Healthcare at 79% of assets, down from 96% a quarter earlier, followed by Technology and Energy.

  • Birchview Capital's largest Q2 2025 buy was KLA: 158,480 shares worth $14.2M.
  • Birchview Capital added most to Ovintiv in Q2 2025, an estimated $2.03M increase.
  • Birchview Capital's biggest Q2 2025 reduction was Bristol-Myers Squibb, cutting an estimated $17.8M.
  • Birchview Capital fully exited SpringWorks Therapeutics in Q2 2025, selling an estimated $365K.
  • Birchview Capital's ten largest holdings make up 57% of its $101M portfolio in Q2 2025.
  • Birchview Capital opened 12 new positions and closed 9 in Q2 2025.
  • Birchview Capital's portfolio value fell 13% quarter-over-quarter to $101M.

Based on Birchview Capital's 13F filing for Q2 2025, filed 14 Aug 2025.